![]() |
RELATED RESOURCES |
SEC Filings:SYRSSYROS PHARMACEUTICALS INC0.8914
|
Year | Type ![]() |
![]() |
Period End Date | |
---|---|---|---|---|
2021 | Form 10-Q* | Quarterly Report* | 05/06/2021 | 03/31/2021 |
Form DEF 14A | Definitive Proxy Statements | 04/29/2021 | 06/08/2021 | |
Form DEFA14A | Definitive Proxy Statements | 04/29/2021 | N/A | |
Form 4 | Insider Transaction | 03/17/2021 | 03/15/2021 | |
Form SC 13G/A | Beneficial Ownership Statement | 03/10/2021 | N/A | |
2020 | Form 10-K* | Annual Report* | 03/04/2021 | 12/31/2020 |
2021 | Form S-8 | Registration statement | 03/04/2021 | N/A |
Form 8-K* | Current Report* | 02/25/2021 | 02/25/2021 | |
Form 4 | Insider Transaction | 02/19/2021 | 02/17/2021 | |
Form 4 | Insider Transaction | 02/19/2021 | 02/17/2021 | |
Form 4 | Insider Transaction | 02/19/2021 | 02/17/2021 | |
Form 4 | Insider Transaction | 02/19/2021 | 02/17/2021 | |
Form 4 | Insider Transaction | 02/19/2021 | 02/17/2021 | |
Form 4 | Insider Transaction | 02/19/2021 | 02/17/2021 | |
Form SC 13G/A | Beneficial Ownership Statement | 02/16/2021 | N/A |